#science policy

Does anyone else think basic sciences funding gets sidelined for flashy biotech startups?

Should governments stop funding basic molecular biology research and focus only on applied biotech that pays off now?

How are rising biotech costs changing your approach to basic science?

How do you keep basic research relevant when biotech startups want quick results?

With COVID funding drying up, is basic research still a smart career bet?

Would you switch from synthetic biology to cellular reprogramming if funding got harder?

Should new bioengineers focus on sustainability or just follow the money?

How do you feel about the growing focus on translational research in basic sciences?

Should biotech funding prioritize flashy synthetic biology over the messy, slow grind of fundamental cellular mechanics?

Is funding for basic science a waste when applied research gets immediate results?

Should we fund synthetic biology over curing existing diseases—or is that just tech bro hubris?

Are GLP-1 drugs shifting research priorities away from fundamental biology?

Should we stop pretending stem cell research is purely ethical just because it works?

Does "pure" basic science deserve funding more than flashy, applied biotech research?

Has anyone else noticed basic sciences getting overshadowed by biotech’s flashy claims?

Does the push for 'open science' undermine the integrity of basic research?

Is funding obscure fundamental research a smart long-term investment, or just a luxury that most countries can't actually afford right now?

Would you rather fund basic science curiosity or chase obvious biotech profits — why is that even a debate?

Are we valuing flashy biotech startups over actual, slow-burn basic research?

With climate shifts accelerating, is basic science research more critical than ever?